Form 4: Columbia Financial, Inc. Executive John Klimowich Reports Changes in Beneficial Ownership
SEC Form 4
John Klimowich, SEVP & Chief Risk Officer of Columbia Financial, Inc., reports transactions involving common stock and stock options.
Summary
- John Klimowich, SEVP & Chief Risk Officer of Columbia Financial, Inc. [CLBK], filed a Form 4 on February 11, 2025, reporting changes in beneficial ownership.
- The report details the acquisition of common stock through a stock-based deferral plan at a price of $16.15 per share.
- Klimowich also holds stock options with exercise prices of $15.60, $15.94, and $16.49, which were granted under the Columbia Financial, Inc. 2019 Equity Incentive Plan.
- The reported transactions include holdings in common stock both directly and indirectly through various plans such as a Stock-Based Deferral Plan, 401(k), ESOP, SERP, SIM, Stock Award II, and Stock Award III.
- Some stock options are fully vested, while others vest in installments commencing on May 1, 2024, and March 6, 2025.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the document primarily reports transactions and holdings without expressing a strong positive or negative outlook. The executive's participation in stock-based plans is a mildly positive signal.
Positives
- The executive's participation in the stock-based deferral plan indicates confidence in the company's future performance.
- The vesting schedules of the stock options and stock awards incentivize long-term commitment from the executive.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.
Stakeholder Impact
- Shareholders can use this information to understand the executive's alignment with their interests.
- Employees participating in similar stock-based plans may be interested in the details of the executive's holdings.
Key Dates
| Date | Description |
|---|---|
| 07/23/2020 | Date of grant for stock options exercisable at $15.60. |
| 05/01/2024 | Commencement of vesting for stock options exercisable at $15.94 and Stock Award II. |
| 03/06/2025 | Commencement of vesting for stock options exercisable at $16.49 and Stock Award III. |
| 02/07/2025 | Date of the reported transaction involving common stock acquisition. |
| 02/11/2025 | Date of Form 4 filing. |
| 03/06/2034 | Expiration date for stock options exercisable at $16.49. |
Keywords
beneficial ownership, Form 4, stock options, common stock, Columbia Financial, Klimowich, equity incentive plan, stock-based deferral plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.